Similarly, a recent study using CpG treatment in a chronic mouse lung inflammation model [31], demonstrated that the treatment-induced amelioration of disease was less dependent on the induction of IFNγ expression but was more associated with an enhanced regulatory T-cell response. This evidence concerns the gene IFNG and inflammatory response.